Camber Capital Management LP Bausch Health Companies Inc. Transaction History

Camber Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $90.8 Million - $146 Million	-4,250,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $3.83 Million - $5.28 Million	-250,000 Reduced 5.56%	4,250,000 $88.4 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $67 Million - $90.6 Million	4,500,000 New	4,500,000 $69.9 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $20.2 Million - $26.3 Million	-1,000,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $17.6 Million - $28.3 Million	1,000,000 New	1,000,000 $18.5 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.77B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.